You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Astrazeneca Pharma India Ltd"

Astrazeneca Pharma India Ltd Announcement under Regulation 30 (LODR)-Change in Directorate

  • 30/12/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 23/12/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Closure of Trading Window

  • 17/12/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

  • 10/12/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 08/12/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 08/12/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 29/11/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Disclosure Of Related Party Transactions

  • 29/11/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 17/11/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Outcome Of The Board Meeting Held On Tuesday November 9 2021

  • 09/11/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday

  • 02/11/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Shareholding for the Period Ended September 30 2021

  • 13/10/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Statement Of Investor Complaints For The Quarter Ended September 2021

  • 13/10/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 13/10/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 13/10/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 29/09/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Astrazeneca Pharma India Limited Receives Import And Market Permission In Form CT-20 From The Drugs

  • 26/09/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Closure of Trading Window

  • 16/09/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)

  • 10/08/2021
  • |
  • bse

Astrazeneca Pharma India Ltd Appointment Of Ms. Revathy Ashok As Independent Director For A Second Term Of 5 Years

  • 10/08/2021
  • |
  • bse
.